Daniel G Welch - Net Worth and Insider Trading
Daniel G Welch Net Worth
The estimated net worth of Daniel G Welch is at least $4 Million dollars as of 2023-06-05. Daniel G Welch is the Director of Seagen Inc and owns about 18,588 shares of Seagen Inc (SGEN) stock worth over $4 Million. Daniel G Welch is also the Director of Intercept Pharmaceuticals Inc and owns about 3,108 shares of Intercept Pharmaceuticals Inc (ICPT) stock worth over $34,654. Details can be seen in Daniel G Welch's Latest Holdings Summary section.
Transaction Summary of Daniel G Welch
Daniel G Welch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel G Welch owns 7 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , Intercept Pharmaceuticals Inc (ICPT) , and Seagen Inc (SGEN) among others .
Click here to see the complete history of Daniel G Welch’s form 4 insider trades.
Insider Ownership Summary of Daniel G Welch
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc | 2015-04-08 | director |
ICPT | Intercept Pharmaceuticals Inc | 2020-05-28 | director |
SGEN | Seagen Inc | 2019-05-20 | director |
AVXS | AveXis Inc | 2018-05-15 | director |
CORI | Corium International Inc | 2014-04-02 | director |
NUVB | Nuvation Bio Inc | 2021-02-10 | director |
GPCR | Structure Therapeutics Inc | 2023-02-02 | director |
Daniel G Welch Latest Holdings Summary
Daniel G Welch currently owns a total of 2 stocks. Among these stocks, Daniel G Welch owns 18,588 shares of Seagen Inc (SGEN) as of May 15, 2023, with a value of $4 Million and a weighting of 99.06%. Daniel G Welch also owns 3,108 shares of Intercept Pharmaceuticals Inc (ICPT) as of July 31, 2017, with a value of $34,654 and a weighting of 0.9399999999999999%.
Latest Holdings of Daniel G Welch
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SGEN | Seagen Inc | 2023-05-15 | 18,588 | 195.42 | 3,632,480 |
ICPT | Intercept Pharmaceuticals Inc | 2017-07-31 | 3,108 | 11.15 | 34,654 |
Holding Weightings of Daniel G Welch
Daniel G Welch Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel G Welch has made a total of 7 transactions in Seagen Inc (SGEN) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Seagen Inc is the sale of 1,864 shares on May 15, 2023, which brought Daniel G Welch around $372,837.
According to the SEC Form 4 filings, Daniel G Welch has made a total of 0 transactions in Intercept Pharmaceuticals Inc (ICPT) over the past 5 years. The most-recent trade in Intercept Pharmaceuticals Inc is the sale of 602 shares on July 31, 2017, which brought Daniel G Welch around $74,606.
Insider Trading History of Daniel G Welch
- 1
Daniel G Welch Trading Performance
Daniel G Welch Ownership Network
Ownership Network List of Daniel G Welch
Ownership Network Relation of Daniel G Welch
Daniel G Welch Owned Company Details

What does Ultragenyx Pharmaceutical Inc do?
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Daniel G Welch is the director of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include EVP and Chief Medical Officer Eric Crombez , CFO & Executive Vice President Mardi Dier , and EVP & Chief Commercial Officer Erik Harris .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Daniel G Welch made no insider transaction in Ultragenyx Pharmaceutical Inc (RARE). Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 15,565 shares made by Karah Herdman Parschauer , a net sale of 3,106 shares made by Theodore Alan Huizenga , and a net sale of 10,265 shares made by John Richard Pinion .
In summary, during the past 3 months, insiders sold 6,390 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 6,390 shares. During the past 18 months, 77,581 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 77,581 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Daniel G Welch Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel G Welch. You might contact Daniel G Welch via mailing address: 4611 University Dr, 4 University Place, Durham Nc 27707.